P-16.1.1 - Prospective Comparison of Sham vs. Placebo Injections: Data from a Trial of Lorecivivint, a Wnt Pathway Inhibitor for Knee Osteoarthritis
Authors
Corresponding Author
Presentation Topic
Osteoarthritis
Poster Rating